Skip to content
Application 050679
- Type
- NDA
- Sponsor
- HOSPIRA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | Yes | Yes |
| 002 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | Yes | Yes |
| 003 | MAXIPIME | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0217 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0218 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0218 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0219 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0219 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |
| 0409-0220 | MAXIPIME | Cefepime | Hospira, Inc. | NDA | Current |